Evofem Biosciences Cash from Financing (TTM) Trends

Evofem Biosciences Inc (EVFM)

0.0153 0.00 (0.00%) USD | OTCM | May 08, 15:59

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	4.776M
September 30, 2023	5.936M
June 30, 2023	7.744M
March 31, 2023	48.51M
December 31, 2022	61.94M
September 30, 2022	70.30M
June 30, 2022	66.38M
March 31, 2022	77.82M
December 31, 2021	90.69M
September 30, 2021	105.74M
June 30, 2021	105.12M
March 31, 2021	180.87M
December 31, 2020	154.23M
September 30, 2020	131.50M
June 30, 2020	131.69M
March 31, 2020	73.17M
December 31, 2019	78.08M
September 30, 2019	75.38M
June 30, 2019	73.90M

Date	Value
March 31, 2019	40.80M
December 31, 2018	54.42M
September 30, 2018	57.41M
June 30, 2018	66.68M
March 31, 2018	29.68M
December 31, 2017	9.212M
September 30, 2017	6.727M
June 30, 2017	-4.633M
March 31, 2017	-4.546M
December 31, 2016	-10.02M
September 30, 2016	-9.965M
June 30, 2016	-5.936M
March 31, 2016	-5.914M
December 31, 2015	0.1386M
September 30, 2015	64.54M
June 30, 2015	69.38M
March 31, 2015	73.25M
December 31, 2014	81.17M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

4.776M

Minimum

Dec 2023

180.87M

Maximum

Mar 2021

81.25M

Average

75.38M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks